News in brief: Non-intensive chemotherapy for older AML patients; Australia wins bronze in health services ranking; Long COVID uncommon in children

Intensive or nonintensive chemotherapy for older AML patients? Reducing the intensity of induction therapy in older patients acute myeloid leukemia (AML) does not routinely improve outcomes, a US study has shown Researchers at the Fred Hutchinson Cancer Research Center, Seattle, used a risk score based on age, increased comorbidity burden and adverse cytogenetic risks to ...

Already a member?

Login to keep reading.

© 2021 the limbic